RT Journal Article
SR Electronic
T1 Need for New Technologies for Detection of Adventitious Agents in Vaccines and Other Biological Products
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP 556
OP 562
DO 10.5731/pdajpst.2014.01012
VO 68
IS 6
A1 Mallet, Laurent
A1 Gisonni-Lex, Lucy
YR 2014
UL http://journal.pda.org/content/68/6/556.abstract
AB From an industrial perspective, the conventional in vitro and in vivo assays used for detection of viral contaminants have shown their limitations, as illustrated by the unfortunate detection of porcine circovirus contamination in a licensed rotavirus vaccine. This contamination event illustrates the gaps within the existing adventitious agent strategy and the potential use of new broader molecular detection methods. This paper serves to summarize current testing approaches and challenges, along with opportunities for the use of these new technologies. LAY ABSTRACT: Testing of biological products is required to ensure the safety of patients. Recently, a licensed vaccine was found to be contaminated with a virus. This contamination did not cause a safety concern to the patients; however, it highlights the need for using new testing methods to control our biological products. This paper introduces the benefits of these new tests and outlines the challenges with the current tests.